Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Immune Enhancing Nutrition in Radical Cystectomy
NCT05822518Completed
- Sponsor
- Menoufia University
- Start
- Jun 2022
- Primary completion
- Nov 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of alanyl glutamine in bladder cancer (2 arms), sponsored by Menoufia University. Primary endpoints: Postoperative complications at 30 days, Wound healing at 30 days and 1 more. Started Jun 2022; status: completed.
02
Drugs
alanyl glutamine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT05822518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05822518.